Business
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference
FRAMINGHAM, Mass. & SALISBURY, England, March 20, 2026--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership Conference taking place in Madrid, Spain from March 26–29, 2026.
About this update from Kalvista Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":474,"url":"https://media.zenfs.com/en/business-wire.com/a17d154d0f394db5527cae7d51ac81ed"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fIACm3dKkxC.IjYtfu1_KA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk0OA--/https://media.zenfs.com/en/business-wire.com/a17d154d0f394db5527cae7d51ac81ed","width":480,"height":474}},"lazy":false},{"type":"text","content":"New interim data from the KONFIDENT-KID trial evaluating sebetralstat in children aged 2-11 accepted for late-breaking oral presentation","length":136,"tagName":"p","attribs":{}},{"type":"text","content":"FRAMINGHAM, Mass. & SALISBURY, England, March 20, 2026--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership Conference taking place in Madrid, Spain from March 26–29, 2026.","length":341,"tagName":"p"},{"type":"text","content":"The following late-breaking abstract will be presented during the poster session on Friday, March 27 and as an oral presentation on Saturday, March 28 at 11:50 am CET:","length":167,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"On-demand Oral Sebetralstat for Hereditary Angioedema Attacks in Children Aged 2-11: Interim Analysis of KONFIDENT-KID: Emel Aygören-Pürsün, Adil Adatia, John Anderson, Shira Benor, Mélisande Bourgoin-Heck, Mauro Cancian, Bob Geng, Eisuke Inage, Aharon Kessel, Majed Koleilat, H. Henry Li, Michael E. Manning, Heloise Reumaux, Raffi Tachdjian, Paola Triggianese, Andrea Zanichelli, Erik Hansen, Ya-Hsiu Chuang, Matthew Iverson, Michael D. Smith, Paul K. Audhya, H. James Wedner.","length":478,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":478,"olType":false},{"type":"text","content":"The following poster presentations will take place during the poster session on Friday, March 27, beginning at 6:10 pm CET:","length":123,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Satisfaction with Sebetralstat for HAE Attacks in Patients Switching from Parenteral On-demand Treatments in KONFIDENT-S: Mauro Cancian, Laurence Bouillet, Teresa Caballero, Tariq El-Shanawa...